Patient 21 Funding: $188M Raised, Series C (2023)

Patient 21 funding overview

Patient 21 is based in Berlin, Germany. Patient 21 has raised $188M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2023. The round record for Patient 21 runs through 2023; nothing later has been disclosed. Investors on record include Pitango Venture Capital, Target Global, Piton Capital, PICO Venture Partners, Bertelsmann Investments, Artian Investments and 3 others. 9 distinct backers are named across the disclosed rounds.

Patient 21 at a glance

Total raised: $188M
Latest round: Series C
Latest round date: May 2023
Headquarters: Berlin, Germany
Notable investors: Pitango Venture Capital, Target Global, Piton Capital, PICO Venture Partners, Bertelsmann Investments, Artian Investments, IPF Partners, Eight Roads Ventures

Frequently asked about Patient 21 funding

How much has Patient 21 raised?: Patient 21 has raised $188M in total disclosed funding across the rounds on record.
Who has invested in Patient 21?: Pitango Venture Capital, Target Global, Piton Capital, PICO Venture Partners, Bertelsmann Investments, Artian Investments are named among the investors backing Patient 21.
What was the latest Patient 21 funding round?: The most recent disclosed round is a Series C, announced in May 2023.
Where is Patient 21 based?: Patient 21 is based in Berlin, Germany.
When did Patient 21 last raise?: The last disclosed Patient 21 round closed in May 2023 at Series C.

Patient 21 totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Berlin below to benchmark round size and investor mix.

Patient 21 Funding: $188M Raised, Series C (2023)

Patient 21 funding overview

Patient 21 at a glance

Frequently asked about Patient 21 funding

Companies related to Patient 21 (27)

Browse related funding lists (7)